Combination Therapy with Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis Induced Clinical Remission in a Crohn's Disease Patient with the Loss of Response to Scheduled Adalimumab Maintenance Therapy: A Case Report

被引：8
|
作者：
Ozeki, Keiji [1 ]
Tanida, Satoshi [1 ]
Mizushima, Takashi [2 ]
Mizoshita, Tsutomu [1 ]
Tsukamoto, Hironobu [1 ]
Hirata, Yoshikazu [1 ]
Murakami, Kenji [1 ]
Shimura, Takaya [1 ]
Kataoka, Hiromi [1 ]
Kamiya, Takeshi [1 ]
Joh, Takashi [1 ]
机构：
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan
[2] Gifu Prefectural Tajimi Hosp, Gifu, Japan
来源：
INTERNAL MEDICINE | 2012年 / 51卷 / 06期
关键词：
refractory Crohn's disease; adalimumab; intensive granulocyte/monocyte adsorptive apheresis; anti-adalimumab antibody; clinical remission; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; NECROSIS-FACTOR; TRIAL; MULTICENTER; INFECTION;
D O I：
10.2169/internalmedicine.51.6801
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 21-year-old Caucasian man with a diagnosis of Crohn's disease (CD) at the age of 14 was admitted to our hospital due to CD flare-up while under scheduled adalimumab (ADA) maintenance therapy. His symptoms remained virtually unchanged following high dose corticosteroid therapy. Seven days later, combination therapy with ADA plus intensive granulocyte/monocyte adsorptive apheresis (GMA) was initiated, which induced clinical remission. Therefore, combination therapy with ADA plus intensive GMA appears to be an effective therapeutic option for patients with severe CD while under scheduled ADA maintenance therapy.
引用
收藏
页码：595 / 599
页数：5
相关论文
共 50 条
  • [1] Effectiveness of combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis in patients with crohn's disease
    Ozeki, Keiji
    Tanida, Satoshi
    Mizoshita, Tsutomu
    Tsukamoto, Hironobu
    Katano, Takahito
    Hayashi, Noriyuki
    Tanaka, Mamoru
    Nishiwaki, Hirotaka
    Ebi, Masahide
    Sawada, Takeshi
    Mori, Yoshinori
    Kubota, Eiji
    Kataoka, Hiromi
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 133 - 133
  • [2] Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn’s disease accompanied by chronic myeloid leukemia
    Tsutomu Mizoshita
    Satoshi Tanida
    Shigeru Kusumoto
    Keiji Ozeki
    Hironobu Tsukamoto
    Masahide Ebi
    Yoshinori Mori
    Hiromi Kataoka
    Takeshi Kamiya
    Takashi Joh
    Clinical Journal of Gastroenterology, 2012, 5 (4) : 302 - 306
  • [3] Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn's disease accompanied by chronic myeloid leukemia
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Kusumoto, Shigeru
    Ozeki, Keiji
    Tsukamoto, Hironobu
    Ebi, Masahide
    Mori, Yoshinori
    Kataoka, Hiromi
    Kamiya, Takeshi
    Joh, Takashi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2012, 5 (04) : 302 - 306
  • [4] Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease
    Tanida, Satoshi
    Mizoshita, Tsutomu
    Ozeki, Keiji
    Katano, Takahito
    Tanaka, Mamoru
    Nishie, Hirotada
    Shimura, Takaya
    Okamoto, Yasuyuki
    Kubota, Eiji
    Kataoka, Hiromi
    Joh, Takashi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (03) : 295 - 300
  • [5] GRANULOCYTE/MONOCYTE APHERESIS AS MAINTENANCE THERAPY IN CROHN'S DISEASE
    Rimmer, P.
    Donnelly, H.
    Preedy, H.
    Makins, R.
    GUT, 2017, 66 : A4 - A4
  • [6] Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
    Wu, Kai-Chun
    Ran, Zhi Hua
    Gao, Xiang
    Chen, Minhu
    Zhong, Jie
    Sheng, Jian-Qiu
    Kamm, Michael A.
    Travis, Simon
    Wallace, Kori
    Mostafa, Nael M.
    Shapiro, Marisa
    Li, Yao
    Thakkar, Roopal B.
    Robinson, Anne M.
    INTESTINAL RESEARCH, 2016, 14 (02) : 152 - 163
  • [7] Adsorptive Granulocyte and Monocyte Apheresis (GMA) induced deep remission in a rare case of ileocolonic Crohn's disease
    Sasaki, Atsuhiro
    Tosa, Masaki
    Oriuchi, Masayoshi
    Ohwada, Izumi
    Komazawa, Daisuke
    Itoh, Hiromichi
    Uno, Kaname
    Ikeda, Tomoyuki
    Takahashi, Seiichi
    Ikeya, Shinichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 179 - 180
  • [8] Maintenance of the Remission Stage of Crohn's Disease with Adalimumab Therapy during Pregnancy
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Tsukamoto, Hironobu
    Ozeki, Keiji
    Katano, Takahito
    Ebi, Masahide
    Mori, Yoshinori
    Kataoka, Hiromi
    Kamiya, Takeshi
    Joh, Takashi
    INTERNAL MEDICINE, 2013, 52 (10) : 1049 - 1053
  • [9] Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor
    Tanida, Satoshi
    Ozeki, Keiji
    Katano, Takahito
    Tanaka, Mamoru
    Shimura, Takaya
    Kubota, Eiji
    Kataoka, Hiromi
    Takahama, Takuya
    Sasoh, Shun
    Kubota, Yoshimasa
    Ban, Tesshin
    Ando, Tomoaki
    Nakamura, Makoto
    Joh, Takashi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2023, 15 (03): : 181 - 186
  • [10] Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
    Tanida, Satoshi
    Ozeki, Keiji
    Kanno, Takuya
    Katano, Takahito
    Sugimura, Naomi
    Nishie, Hirotada
    Iwasaki, Hiroyasu
    Tanaka, Mamoru
    Shimura, Takaya
    Kubota, Eiji
    Kataoka, Hiromi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (10-11): : 510 - 514
12345